Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Tommasi Ruben Create: Alert

All | News | Filings
Date FiledTypeDescription
07/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 22,816 options to buy @ $4.98, valued at $113.6k
Granted 15,210 options to buy @ $2.44, valued at $37.1k
Disposed/sold 15,632 options to buy @ $6.85, valued at $107.1k
Granted 12,024 options to buy @ $2.44, valued at $29.3k
Disposed/sold 50,411 options to buy @ $15, valued at $756.2k
Granted 28,006 options to buy @ $2.44, valued at $68.3k
Disposed/sold 56,500 options to buy @ $5.66, valued at $319.8k
Granted 43,460 options to buy @ $2.44, valued at $106k
01/19/2022 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
11/03/2021 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Paid exercise price by delivering 3,669 shares @ $2.94, valued at $10.8k
10/20/2021 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 25,000 shares @ $0
Sold 3,759 shares @ $3.19, valued at $12k
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2020 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 50,000 options to buy @ $4.94, valued at $247k
01/22/2019 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 56,500 options to buy @ $5.66, valued at $319.8k
12/26/2018 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Exercised 11,788 options to buy @ $3.74, valued at $44.1k
Exercised 10,236 options to buy @ $3.11, valued at $31.8k
09/27/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2018 3 Tommasi Rubin (Chief Science Officer) has filed a Form 3 on Entasis Therapeutics Holdings Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy